Clinical Trials for Arrowhead Pharmaceuticals

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Study of ARO-APOC3 in Adults With Dyslipidemia

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)